Bokf, Na Iovance Biotherapeutics, Inc. Transaction History

Bokf, Na

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$6.38 - $18.33 $4,198 - $12,061	658 Added 1.66%	40,248 $444,000
Q1 2022 May 13, 2022	BUY	$12.38 - $19.1 $59,956 - $92,501	4,843 Added 13.94%	39,590 $659,000
Q4 2021 Mar 11, 2022	BUY	$16.55 - $27.63 $575,062 - $960,059	34,747 New	34,747 $664,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

Stay updated on Bokf, Na with notifications on news.